In 1000 adults with migraine and patent foramen ovale (984 analysed), 12 weeks of aspirin, clopidogrel or rivaroxaban were non-inferior to metoprolol for ≥50% response (61.7%, 66.8%, 78.4% v 61.8%); rivaroxaban was superior. No major bleeding.
RCTn = 1,000
Li et al. Antithrombotic treatment for migraine in patients with patent foramen ovale: multicentre, randomised, active controlled, open label trial